Trials / Unknown
UnknownNCT06137053
Effect of Telitacicept on Transitional Regulatory B Cells in Patients With Systemic Lupus Erythematosus
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Yanfeng Hou · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- —
Summary
The effect of Telitacicept treatment on the changes of transitional regulatory B lymphocyte T1, T2B cell subsets and plasma blasts and the expression levels of cytokines IL-10, IL-35, April and BAFF in SLE.
Conditions
Timeline
- Start date
- 2022-11-01
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2023-11-18
- Last updated
- 2023-11-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06137053. Inclusion in this directory is not an endorsement.